Review of Current Immunologic Therapies for Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory disease of apocrine gland-bearing skin which affects approximately 1–4% of the population. The disease is more common in women and patients of African American descent and approximately one-third of patients report a family history....
Main Authors: | Victoria K. Shanmugam, Nadia Meher Zaman, Sean McNish, Faye N. Hant |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | International Journal of Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2017/8018192 |
Similar Items
-
Hidradenitis Suppurativa
by: Lam, J.M, et al.
Published: (2022) -
Systematic review of immunomodulatory therapies for hidradenitis suppurativa
by: Lim SYD, et al.
Published: (2019-05-01) -
Hidradenitis suppurativa and intimacy
by: G. Jemec, MD, DMedSci
Published: (2018-06-01) -
Multimodal management of hidradenitis suppurativa
by: Gregor B.E. Jemec, MD, DMSc
Published: (2020-06-01) -
Surgical options in hidradenitis suppurativa
by: Sree S Kolli, et al.
Published: (2019-01-01)